跳至主要内容
临床试验/NCT05144971
NCT05144971已完成不适用

StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation

Nova Biomedical1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2021年10月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
175
试验地点
1
主要终点
Nova StatStrip A Glucose/Creatinine Meter System

研究概览

简要总结

The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.

详细描述

To assess the performance of the StatStrip A Glucose/Creatinine assay in the hands of lay users on capillary whole blood obtained by finger stick and compare with the performance characteristics to a central laboratory traceable reference method.

To assess the Ease of Use of the StatStrip Glucose / Creatinine Meter System in the hands of the intended lay users. Lay users will be provided with all package insert sheets, a Quick Reference Guide and Instructions for Use (IFU) Manual. No training, coaching, or prompting will be provided to the lay users other than clarifying the protocol.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects (≥ 18 years old) with diabetes.
  • Adult subjects (≥ 18 years old) with kidney diseases (CKD, ESRD) and/or in dialysis.
  • Adult subjects (≥ 18 years old) that are healthy.
  • Subjects willing to complete all study procedures.
  • Subjects whose pre-screen glucose or creatinine medical history is deemed of value by the study site
  • Subjects able to read, write, speak in English.

排除标准

  • Subjects unable to consent to participating in the study.
  • Subjects possessing a cognitive disorder or other condition, which, in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study.
  • Subjects taking prescription anticoagulants (such as Warfarin or Heparin) or has clotting problems that may prolong bleeding.
  • Subjects having hemophilia or any other bleeding disorder.
  • Subjects having an infection with a blood borne pathogen (e.g. HIV, hepatitis).
  • Subjects working for a medical device or diagnostic company.

结局指标

主要结局

Nova StatStrip A Glucose/Creatinine Meter System

时间窗: 20 days

The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician. The two parameters for the outcome measure in this study are glucose and creatinine. The unit of measure for glucose and creatinine is mg/dL and mmol/L, respectively.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验